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Evidence that CD40þ neuroblastoma cells undergo apoptosis
following interaction with CD40L
I Airoldi
1, S Lualdi
1, S Bruno
2, L Raffaghello
1, M Occhino
1, C Gambini
3, V Pistoia*,1 and MV Corrias
1
1Laboratory of Oncology, G Gaslini Institute, Largo G Gaslini, 5, 16148 Genova, Italy;
2Department of Experimental Medicine, Section of Human
Anatomy, University of Genova, Genova, Italy;
3Service of Pathology, G Gaslini Institute, 16148 Genova, Italy
Tumour cells display low to absent expression of costimulatory molecules. Here, we have investigated the expression of
costimulatory molecules (CD40, CD80, CD86, PD-1L, B7H2, OX40L and 4-1BBL) in human neuroblastoma (NB) cells, since virtually
no information is available on this issue. Both established NB cell lines and primary tumours were tested by RT–PCR and flow
cytometry. Neuroblastoma cell lines expressed the transcripts of all costimulatory molecule genes, but not the corresponding
proteins. Culture of NB cell lines with human recombinant (r)IFN-g induced surface expression of CD40 in half of them. Primary NB
cells showed CD40, CD80, CD86, OX40L, 4-1BBL, but not PD-1L and B7H2, mRNA expression. Surface CD40 was consistently
detected on primary NB cells by flow cytometry. Interferon-g gene-transfected NB cells expressed constitutively surface CD40 and
were induced into apoptosis by incubation with rCD40L through a caspase-8-dependent mechanism. CD40 may represent a novel
therapeutic target in NB.
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Costimulatory molecules play an indispensable role in the
induction and maintenance of T-cell activation. Costimulatory
signals promote T-cell proliferation, cytokine production and
effector functions (Chambers et al, 2001). T-cell activation through
T-cell receptor (TCR) and cluster designation 28 (CD28) induces
CD8þ T lymphocytes to acquire cytolytic functions and CD4þ
cells to differentiate into T Helper 1 (TH1) or TH2 cells (Lenschow
et al, 1996). Some costimulatory molecules, such as CD40, CD80
and CD86, are constitutively expressed by professional antigen-
presenting cells (APCs), and rapidly upregulated in the course of
antigen presentation to T cells (Chambers et al, 2001). The binding
of CD80 and CD86 on APC to CD28 on T cells is followed by the
upregulation of additional costimulatory molecules on the latter
cells, that amplify (e.g. inducible costimulator (ICOS) and 4-1BB;
Akiba et al, 1999; Wang et al, 2000; Cannons et al, 2001; Dong et al,
2001) or downregulate (e.g. programmed death 1 (PD-1); Freeman
et al, 2000) T-cell activation upon binding to their receptors on
APC. On the other hand, interaction between CD80 and CD86 on
APC with CTLA-4 on T cells delivers inhibitory signals to the latter
cells that dampen ongoing immune responses (Chambers, 2001).
T-cell interaction with nonprofessional APC-presenting anti-
genic peptides in the context of HLA-class I or II molecules, but in
the absence of costimulatory molecules, leads to T-cell anergy or
apoptosis (Chambers, 2001).
Most tumour cells are poor APC because of the low or absent
expression of costimulatory molecules (Hurwitz et al, 2000), but
enforced expression of some of these (e.g. CD80, B7H2 or 4-1BBL)
by gene transfer has resulted in enhanced antitumour responses
and tumour rejection in different animal models (Wu et al, 1995;
Weinberg et al, 2000; Liu et al, 2001).
Neuroblastoma (NB) is the most common solid tumour in young
children and carries a poor prognosis in more than half of the
cases, because of its frequent presentation as metastatic disease at
diagnosis (Brodeur et al, 1988). High-dose chemotherapy followed
by rescue with autologous haematopoietic stem cells has not
improved significantly the outcome of advanced-stage NB patients.
So far, two groups have reported that CD80 or CD86 gene
transfer in murine NB cells decreases their tumorigenicity
(Katsanis et al, 1995; Enomoto et al, 1997), whereas virtually no
data are available on the expression of costimulatory molecules in
human NB cells (Uc¸ar et al, 1995). In this perspective, we have
investigated the expression of the CD40, CD80, CD86, PD-1L,
B7H2, OX40L and 4-1BBL costimulatory molecules in 10 human
NB cell lines, as well as in primary tumour cells isolated from NB
patients. Here, we show that incubation of surface CD40þ NB
cells with CD40 ligand (L) triggers their apoptosis through a
caspase-8-dependent mechanism.
RESULTS
Expression of CD40, CD80, CD86, PD-1L, B7H2, OX40L and
4-1BBL in NB cell lines
A total of 10 human NB cell lines were tested for the expression of
costimulatory molecules by RT–PCR and, when reagents were
available, by flow cytometry.
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yCD40 and B7H2 mRNA were detected in all the cell lines but GI-
ME-N, GI-CA-N and IMR-32. CD80 and CD86 transcripts were
present in the majority of NB cell lines; exceptions were LAN-5,
that did not express the CD80 gene, as well as IMR-32 and GI-CA-
N cells, that did not show CD80 or CD86 transcripts (Figure 1).
PD-1L, OX40L and 4-1BBL mRNA were found in all the cell lines
(Figure 1). The specificity of the amplified bands was confirmed by
sequencing.
In subsequent experiments, surface expression of CD40, CD80,
CD86, 4-1BBL and OX40L on the 10 NB cell lines was investigated
by flow cytometry. Cells were stained with CD40, CD80 and CD86
monoclonal antibodies (mAbs), as well as with the rhOX40:Fc and
rh4-1BB:Fc fusion proteins. No costimulatory molecule was
detected on the surface of any cell line, with the exception of
OX40L that was expressed by GI-CA-N and IMR-32 cells only (not
shown).
Recombinant (r) interferon-c (IFN-c) treated NB cell lines
express surface CD40
In further experiments, NB cell lines were incubated with human
rIFN-g for 72h, since this cytokine upregulates the expression of
various costimulatory molecules (Aicher et al, 2000; Wagner et al,
2002). Thereafter, costimulatory molecule gene expression was
investigated by RT–PCR and flow cytometry.
GI-ME-N, GI-CA-N and IMR-32 cells showed de novo expression
of the CD40 gene (Figure 2A). Furthermore, the CD80 transcript
was induced in LAN-5 cells, and B7H2 mRNA was detected in GI-
ME-N cells (data not shown).
To investigate whether or not CD40 mRNA expression was
upregulated by incubation with rIFN-g, cells from the LAN-5, SK-
N-SH, SK-N-BE 2(C), SK-N-BE and ACN cell lines were subjected
to semiquantitative RT–PCR following 72h culture with rIFN-g or
with medium alone (Figure 2B). A clear-cut increase of CD40
mRNA was observed after incubation of the LAN-5, SK-N-SH, SK-
N-BE 2(C), and ACN cell lines, but not in the SK-N-BE cell line,
with rIFN-g (Figure 2B).
Next, CD40 surface expression was investigated by flow
cytometry in rIFN-g treated NB cell lines. ACN, GI-ME-N, LAN-
5, SK-N-BE2(C), SK-N-SH and GI-CA-N cell lines were found to
express surface CD40 on a minority of cells (range: 6–13%) (see
Table 1). One representative experiment carried out with the LAN-
5 cell line is shown in Figure 2C, together with surface CD40
staining of Raji Burkitt’s lymphoma cells shown as reference.
Surface CD40 was detected in cell lines that either displayed
constitutive expression of the CD40 transcript (ACN, LAN-5, SK-
N-BE2(C) and SK-N-SH), or expressed CD40 mRNA only following
incubation with rIFN-g (GI-ME-N and GI-CA-N).
Additional experiments were carried out to investigate whether a
representative surface CD40  (i.e. GI-LI-N) and two representative
CD40þ (i.e. SK-N-BE2(C) and LAN-5) cell lines contained
intracellularly the CD40 protein following incubation with rIFN-g
or with medium alone. As shown in Figure 2C LAN-5 cells did not
express intracellular CD40, as assessed by flow cytometry, unless
they were incubated with rIFN-g; similar results were obtained
with the SK-N-BE2(C) cell line (not shown). In contrast, no
intracellular CD40 protein was detected in GI-LI-N cells upon
culture with either rIFN-g or medium alone (not shown). These
findings indicate that intracellular and surface CD40 expression
are induced coordinately in rIFN-g-responsive NB cell lines.
In view of the ability of rIFN-g to upregulate CD40 expression on
NB cells, ACN cells stably transfected with a plasmid containing
the human IFN-g gene or with the empty plasmid were tested for
CD40 surface expression. The detailed characterisation of this cell
line will be the matter of a separate report; suffices here to say that
CD40 was consistently detected by flow cytometry on 50–60% of
the cells transfected with the plasmid carrying the IFN-g gene
(Figure 2D, right panel), but not on cells transfected with the
empty plasmid (Figure 2D, left panel). The proportion of CD40þ
cells in IFN-g gene transfected ACN cells remained stable over a 6
month period, with little fluctuations that did not exceed 10–15%.
Expression of CD40, CD80, CD86, PD-1L, B7H2, OX40L and
4-1BBL in primary NB cells
First, costimulatory molecule gene expression was investigated in
GD2þ neuroblasts isolated from four tumours (from one stage 1,
one stage 2, one stage 3 and one stage 4 patients) by
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Figure 1 Costimulatory molecule gene expression in human NB cell
lines, as assessed by RT–PCR. From left to right: MW¼molecular weight
markers; NC¼negative control, represented by water in the place of
cDNA; PC¼positive control, represented by normal peripheral blood
MNC stimulated with phytohaemagglutinin for 6h; lanes from 4 to 13, 10
NB cell lines are shown. The first upper panel shows the amplification
product of the G3PDH housekeeping gene tested as control. On the right
side of each panel, the expected MW of the amplification products are
shown.
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yimmunomagnetic bead manipulation. The GD2 disialoganglioside
is a reliable surface marker of NB cells (Cheung et al, 1986; Mujoo
et al, 1987).
The purity of the GD2þ cell suspensions was checked by RT–
PCR with CD45 and HLA-DRb gene-specific primers (Figure 3).
Since these genes are not expressed in NB cells (Komada et al,
1998; Corrias et al, 2001), further experiments were carried out
only with GD2þ cell suspensions that tested negative for CD45
and HLA-DRb mRNA expression. The latter transcripts were
detected, as expected, in GD2  cell fractions.
Figure 3 shows the patterns of costimulatory molecule gene
expression in GD2þ and GD2  cell fractions from two tumours
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Figure 2 (A) Expression of CD40 mRNA, as assessed by RT–PCR, in GI-ME-N, GI-CA-N and IMR-32 cell lines cultured with medium alone or with
human rIFN-g. From left to right: MW¼molecular weight markers; NC¼negative control, represented by water in the place of cDNA; PC¼positive
control, represented by normal peripheral blood MNC stimulated with phytohaemagglutinin for 6h; GI-ME-N cells cultured in the absence (medium) or
presence of rIFN-g (IFN-g), GI-CA-N cells cultured in the absence (medium) or presence of rIFN-g (IFN-g), IMR-32 cells cultured in the absence (medium)
or presence of rIFN-g (IFN-g). (B) Semiquantitative RT–PCR analysis for CD40 mRNA expression in LAN-5, SK-N-SH, SK-N-BE 2(C), SK-N-BE and ACN
cells cultured in the absence (medium) or presence of rIFN-g (IFN-g) for 72h. On the right side of each panel, the expected MW of the amplification
products are shown. (C) Expression of CD40 in LAN-5 cells. From left to right: (1) cells cultured in medium for 72h; (2) cells cultured in the presence of
rIFN-g for 72h, and stained with a PE-conjugated CD40mAb (open profile) or with a PE-conjugated isotype matched murine mAb of irrelevant specificity
(dark profile); (3) cells cultured as in (2) and stained after permeabilisation with a PE-conjugated CD40mAb (open profile) or with a PE-conjugated isotype
matched murine mAb of irrelevant specificity (dark profile). The fourth histogram on the right side of the figure shows CD40 staining of Raji Burkitt’s
lymphoma cell line with a PE-conjugated CD40mAb (open profile) or with a PE-conjugated isotype matched murine mAb of irrelevant specificity (dark
profile). Cells were cultured 72h in medium before staining. (D) Expression of surface CD40 in ACN cells transfected with empty plasmid (left) or with IFN-
g gene carrying plasmid (right). Cells were stained with a PE-conjugated CD40mAb (open profiles) or with a PE-conjugated isotype matched murine mAb of
irrelevant specificity (dark profiles).
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of the four tested with similar results. Primary GD2þ neuroblasts
were found to express CD40, CD80, CD86, OX40L and 4-1BBL, but
not PD-1L or B7H2, mRNA. In contrast, all of the costimulatory
gene transcripts were consistently detected in the GD2  cell
fractions (Figure 3).
Flow cytometric analysis of six bone marrow (BM) aspirates (all
from stage 4 patients) performed for diagnostic purposes was
subsequently carried out by double staining for GD2 and CD40,
CD80, CD86, OX-40L or 4-1BBL. All BM aspirates were found to
contain GD2þ neuroblasts (Figure 4A) with the following figures:
BM1 50.8%, BM2 38.7%, BM3 65.7%, BM4 25.6%, BM5 30.2% and
BM6 36.4%. GD2þ cells coexpressing CD40 were found in all BM
samples and ranged from 10 to 65% (mean 35%). GD2þ cells
coexpressing CD86 were detected in three BM samples (range 10–
20%, mean 15%).
Figure 4B and C shows the results of immunophenotypic
analyses of CD40 and CD86 expression on neuroblasts from three
representative BM aspirates. As apparent, GD2þ neuroblasts
expressed CD40 in both samples, whereas coexpression of CD86
was detected only in one case.
Neuroblasts tested always negative for CD80, OX40L or 41BBL
staining.
CD40L triggers apoptosis of NB cells expressing
surface CD40
Previous studies have shown that ligation of CD40 on the surface
of tumour cells by CD40L can induce inhibition of cell
proliferation and apoptosis (Hirano et al, 1999; Ghamande et al,
2001; Bugajska et al, 2002; Szocinski et al, 2002). Therefore,
subsequent experiments were addressed at investigating whether
CD40þ NB cells were susceptible to CD40L-induced apoptosis.
First, IFN-g pretreated ACN, GI-ME-N, LAN-5, SK-N-BE2(C),
SK-N-BE, SK-N-SH, GI-CA-N and IMR-32 cell lines were incubated
for 48h with medium alone or with rCD40L, and tested for
apoptosis by double staining for annexin V and propidium iodide
(Koopman et al, 1994). As shown in Table 1, all the CD40þ cell
lines were found to undergo apoptosis in the presence of rCD40L,
while the two CD40  cell lines were unaffected by rCD40L
treatment.
To better investigate the kinetics of CD40L-induced apoptosis
and the mechanism involved, subsequent experiments were carried
with IFN-g gene-transfected ACN cells. To this end, IFN-g gene-
transfected ACN cells were incubated for 5–72h with medium
Table 1 Surface CD40 expression and apoptosis induction in
neuroblastoma cell lines treated sequentially with rIFN-g and rCD40L
Cell Lines
Percentage of
CD40+ cells after
IFN-c treatment
a
Percentage of CD40+
apoptotic cells after
rCD40L treatment
b
ACN 16 97.2
LAN-1 ND ND
LAN-5 12 98.5
GI-LI-N ND ND
GI-ME-N 5 86.3
GI-CA-N 10 94.8
SK-N-SH 3 99.6
SK-N-BE 0 0
SK-N-BE 2(C) 14 89.7
IMR-32 0 0
aCells were cultured for 72h with 1000Uml
 1 rIFN-g and stained with a CD40mAb.
Results are percentage of positive cells;
bCells that had been pretreated with rIFN-g
as in (a) were washed and incubated for 48h with rCD40L (1mgml
 1) and double
stained with annexin and propidium iodide.
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Figure 3 Costimulatory molecule gene expression in primary NB cells,
as assessed by RT–PCR. The results of the experiments carried out with
two tumours out of the four studied are shown. Neuroblasts were isolated
as GD2þ cells by immunomagnetic bead manipulation. From left to right:
MW¼molecular weight markers; NC¼negative control, represented by
water in the place of cDNA; PC¼positive control, represented by normal
peripheral blood MNC stimulated with phytohaemagglutinin for 6h; NB
(GD2þ) cells from patient 1 (Pt1); GD2  cell fraction from patient 1 (Pt
1); NB (GD2þ) cells from patient 2 (Pt 2); GD2  cell fraction from patient
2 (Pt 2). The first upper panel shows the amplification product of the
G3PDH housekeeping gene tested as control. On the right side of each
panel, the expected MW of the amplified bands are shown.
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fected with the human CD40L gene, or with the empty vector.
A dot-plot representative of these experiments is shown in
Figure 5B, where cell apoptosis was tested after 24h culture with
rCD40L.
Figure 5B shows the results of time course experiments in which
IFN-g gene-transfected ACN cells were cultured in the presence or
absence of rCD40L for 5, 24 or 48h. Results are expressed as mean
percentages (from four independent experiments) of CD40þ cells
undergoing apoptosis. These values were obtained by dividing the
percentage of apoptotic cells in CD40L containing cultures by the
percentage of CD40þ cells in control cultures for each time point.
As apparent, apoptosis was detected in IFN-g gene-transfected
ACN cells that had been cultured with rCD40L for 5, 24 and 48h.
At 72h, apoptotic cells were no longer found in these cultures (not
shown). Cells kept in medium alone for the same time intervals
showed only minimal levels of apoptosis (Figure 5B).
The above experiments were repeated by incubating for the
same times IFN-g gene-transfected ACN cells with NIH-3T3
murine fibroblasts, either transfected with the human CD40L gene
or with the empty vector for the same times. Apoptosis of ACN
cells was detected with the same kinetics as above following
incubation with the former, but not the latter, transfectant (data
not shown). These results indicate that soluble and insoluble
CD40L were equally effective at inducing apoptosis of IFN-g gene-
transfected ACN cells.
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Figure 4 Surface expression of CD40 and CD86 on primary, GD2þ neuroblastoma cells, as assessed by flow cytometry. (A) Representative GD2
stainings of two BM samples shown as dot-plots. From left to right: cells stained with an irrelevant subclass-matched mAb (1,3) or with test mAb (2, 4)
followed by incubation with FITC-conjugated secondary anti-mouse Ig antibodies. (B) Neuroblasts from one BM aspirate were double stained for GD2 and
CD40 or CD86. Two-D dot-plots are shown. From left to right: cells were incubated with a PE-conjugated irrelevant subclass matched mAb (1) or PE-
conjugated CD40 (2) or CD86 (3), followed by treatment with FITC-conjugated secondary anti-mouse Ig antibodies. (C, D) Neuroblasts from two BM
aspirates were double stained for GD2 and CD40 or CD86. The profiles shown have been obtained by setting the gate on GD2þ neuroblasts. Left panels:
no staining (o1.5% positive cells) was detected when an IgG2a antibody of irrelevant specificity (anti-GD2 control), followed by FITC-conjugated goat anti-
mouse IgG2a antibodies, and a PE-conjugated IgG1mAb (CD40 or CD86 control) of irrelevant specificity were tested together. Middle panels: neuroblasts
were double stained with a GD2 mAb, followed by FITC-conjugated goat anti-mouse IgG2a antibodies, and with a PE-conjugated CD40mAb. Right panels:
Neuroblasts were double stained with a GD2 mAb, followed by FITC-conjugated goat anti-mouse IgG2a antibodies, and with a PE-conjugated CD86mAb.
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8 dependent
CD40 belongs to the TNF receptor superfamily, whose components
trigger cell apoptosis through caspase-8 activation (Ashkenazi and
Dixit, 1998; Grell et al, 1999; Eliopoulos et al, 2000). We therefore
investigated whether this mechanism operated also in CD40-
expressing NB cells. IFN-g gene-transfected ACN cells were treated
overnight with the recently developed caspase-8 selective inhibitor
Z-LE(Ome)-TD(Ome)-FMK (Z-LETD-FMK) (Ahmad and Shi,
2000), before being incubated with rCD40L. Z-LETD-FMK was
then added every 24h to the cultures and apoptosis was assessed
by flow cytometry.
As shown in Figure 5B, incubation of IFN-g gene-transfected
ACN cells with Z-LETD-FMK decreased apoptosis induced by
CD40L after 5h by approximately 70% and abrogated programmed
cell death in cells tested at 24 and 48h. Z-LETD-FMK alone did not
cause apoptosis of IFN-g gene-transfected ACN cells cultured up to
48h (Figure 5B). The results are shown as mean percentages (from
four independent experiments) of CD40þ cells undergoing
apoptosis.
Finally, involvement of caspase-8 in CD40L-induced apoptosis
of NB cells was demonstrated by Western blot experiments in
which IFN-g gene-transfected ACN cells were cultured with
rCD40L or medium in the presence or absence of Z-LETD-FMK
for 15 or 24h (Figure 5C). After 15h culture with rCD40L, the
specific 17kDa protein corresponding to active caspase-8 was
clearly detectable in IFN-g gene-transfected ACN cells. Treatment
with Z-LETD-FMK strongly reduced the expression of activated
caspase-8. After 24h treatment with rCD40L, the band correspond-
ing to activated caspase-8 was faint; addition of Z-LETD-FMK to
the cultures led to its complete disappearance (Figure 5C). Taken
together these findings demonstrate the direct role of caspase-8 in
rCD40L-induced apoptosis of CD40þ NB cell lines.
DISCUSSION
Expression of seven costimulatory molecules (CD40, CD80, CD86,
PD-1L, B7H2, OX40L and 4-1BBL) has been investigated in a panel
of human NB cell lines and in primary NB cells. The rationale for
this study came from the following: (i) costimulatory molecules are
poorly expressed on the surface of malignant cells (Hurwitz et al,
2000), (ii) transfer of some costimulatory molecule coding genes in
tumour cells leads to tumour rejection in vivo (Katsanis et al, 1995;
Enomoto et al, 1997) and (iii) virtually no information is available
as to costimulatory molecule expression in human NB (Uc¸ar et al,
1995).
Costimulatory gene transcripts were expressed constitutively
in the majority of cell lines, but the CD40, CD80, CD86, OX40L and
4-1BBL proteins were not detected on the cell surface. Primary NB
cells displayed a similar profile of gene expression, but PD-1L and
B7H2 transcripts were not detected.
CD86 was detected on the surface of neuroblasts from three out
of six BM cell suspensions tested. CD80 and/or CD86 expressed on
neoplastic cells may induce NK cell activation, possibly because of
the triggering of CD80/CD86 ligands alternative to CD28 or CTLA-
4 (Wilson et al, 1999). In addition, targeting of CD86 and/or CD80
in experimental tumours, even of low immunogenicity, was found
to promote antitumour CTL responses (Moro et al, 1999). Thus,
our preliminary observation on CD86 expression in some NB cases
deserves further investigation.
The most important finding of this study is the constitutive
expression of CD40 mRNA and protein in all of the tumour
samples tested. In contrast, the majority of NB cell lines were
found to express constitutively CD40 mRNA, but surface CD40 was
detected on a minority of cells in the individual cell lines, only
following culture with rIFN-g. Additional experiments were
performed to investigate whether lack of expression of surface
CD40 in some NB cell lines following treatment with rIFN-g was
related to defects in CD40 protein transport. The finding that
surface CD40 expression was paralleled by accumulation of
intracellular CD40 protein in rIFN-g-responsive cell lines, whereas
no intracellular CD40 was detected in unresponsive cell lines,
suggest that the inability of the latter cell lines to express the CD40
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Figure 5 Apoptosis of IFN-g gene-transfected ACN cells following
incubation with rCD40L and their rescue upon exposure to the selective
caspase-8 inhibitor Z-LETD-FMK. (A) Quadrant analysis of annexin V vs
propidium iodide staining of IFN-g gene transfected ACN cells incubated
24h with rCD40L. One representative experiment is shown. (B) IFN-g
gene-transfected ACN cells were cultured for 5, 24 and 48h with medium
alone, rCD40L, rCD40L together with Z-LETD-FMK, or Z-LETD-FMK
alone. The results, which represent the means from four independent
experiments, are shown as percent CD40þ cells undergoing apoptosis
7s.d. These values were calculated as follows. The percentages of
apoptotic cells in CD40L containing cultures, detected by double staining
with annexin V and propidium iodide, were divided by the percentage of
CD40þ cells determined at any time interval in control cultures and
multiplied by 100. (C) Western blot analysis performed on IFN-g gene
transfected ACN cells incubated with medium or rCD40L for 15 or 24h, in
the absence or presence of the caspase-8 inhibitor Z-LETD-FMK. The band
corresponding to activated 17kDa caspase-8 is indicated by the arrow on
the right side of the figure.
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protein trafficking.
To get further insight into the mechanisms involved in the rIFN-
g-mediated induction of CD40 protein in NB cell lines, CD40
mRNA expression was evaluated by semiquantitative RT–PCR in
cell cultured with rIFN-g or medium alone. These experiments
showed that surface CD40þ cell lines displayed an evident
upregulation of CD40 mRNA following incubation with rIFN-g,
whereas a surface CD40  cell line did not, suggesting that
regulation of CD40 expression occurred mainly at the transcrip-
tional level. However, additional, post-transcriptional mechanisms
may be involved, since IMR-32 cells, that acquired de novo
expression of CD40 mRNA following incubation with rIFN-g, failed
to express surface CD40.
The discrepancies in CD40 expression between NB cell lines and
fresh tumour cells may be related to the presence of in vivo factors
(e.g. IFN-g) capable of upregulating surface CD40 in the tumour
microenvironment.
CD40 expression is a common feature of haematopoietic and
nonhaematopoietic tumours (Hirano et al, 1999; Ghamande et al,
2001; Bugajska et al, 2002; Szocinski et al, 2002). Previous studies
have shown that interaction of tumour cell-associated CD40 with
CD40L can lead to different consequences: (i) CD40 triggering
induces upregulation of HLA and adhesion molecules on the
surface of tumour cells (Ahmad and Shi, 2000), thus enhancing
their immunogenicity, and (ii) exposure of neoplastic cells to
soluble CD40L results into inhibition of cell proliferation and
induction of cell death by apoptosis (Hirano et al, 1999; Ghamande
et al, 2001; Bugajska et al, 2002; Szocinski et al, 2002).
Furthermore, soluble CD40L was found to induce tumour
regression in SCID mice implanted with human breast cancer
cells (Hirano et al, 1999).
The functional role of surface CD40 in neuroblastoma cells was
investigated using both IFN-g-treated cell lines and the ACN cell
line transfected with a plasmid carrying the human IFN-g gene. In
these experiments, cells were incubated with soluble or insoluble
CD40L and tested for apoptosis. All CD40þ neuroblastoma cells
underwent massive apoptosis following 48h culture with CD40L.
Since CD40 belongs to the TNF receptor superfamily that
triggers apoptosis by caspase-8 activation (Ashkenazi and Dixit,
1998; Grell et al, 1999; Eliopoulos et al, 2000), experiments were
performed in which CD40L-induced apoptosis of ACN cells was
investigated in the presence or absence of Z-LETD-FMZ, a selective
inhibitor of caspase-8 (Ahmad and Shi, 2000). It was found that
apoptosis of CD40þ ACN cells cultured with CD40L was
abrogated by Z-LETD-FMZ, thus pointing to the involvement of
caspase-8 in our experimental model. The latter conclusion was
directly supported by Western blot experiments showing activa-
tion of caspase-8 in NB cells following CD40–CD40L interaction
and its block by exposure to the Z-LE-TD-FMK inhibitor.
Previously, it was shown that the CD40 cytoplasmic C terminus
lacks a death domain homology with the cytotoxic members of the
TNF-R superfamily, such as Fas, TNF-R1 and TNF-related
apoptosis-inducing ligand (TRAIL) (Ashkenazi and Dixit, 1998;
Grell et al, 1999; Eliopoulos et al, 2000). CD40L-induced apoptosis
in neoplastic cells was found to depend on the membrane proximal
domain of the molecule (Eliopoulos et al, 2000) and to involve
endogenous production of TNF in the target cell, leading to
autotropic or paratropic activation of TNF-R1 and, eventually, to
TNF-R1-mediated cytotoxicity (Grell et al, 1999). In this connec-
tion, human NB cell lines were reported to express surface TNF-R1
and TNF-R2, as well as TNF mRNA (Goillot et al, 1992; Montaldo
et al, 1994). Thus, it is conceivable that NB cell apoptosis induced
by CD40L takes place through the TNF/TNF-R1 pathway identified
in other experimental models.
Recently, caspase-8 gene expression was found to be reduced or
absent in neoplastic cells from patients with metastatic NB
(Hopskins-Donaldson et al, 2000; Teitz et al, 2001). This feature
has been related to methylation of caspase-8 gene promoter
regions (Teitz et al, 2000; Banelli et al, 2002) or, more rarely, to
deletion of the caspase-8 gene (Teitz et al, 2000). In the former
case, demethylating agents, such as 5-aza-20-deoxycytidine, or IFN-
g can restore caspase-8 gene expression in NB cells (Fulda et al,
2001; Banelli et al, 2002; Fulda and Debatin, 2002), whereas this
cannot happen in the latter case. Thus, the potential therapeutic
use of rCD40L in NB patients may depend on preliminary in vitro
assessment of caspase-8 activation in tumour cells under baseline
conditions and following culture with demethylating agents or
IFN-g. Thereafter, combination therapy with either of the latter
molecules and rCD40L may be envisaged.
Triggering of dendritic cell-associated CD40 leads to increased
production of IL-12, which activates NK cells and drives T helper 1
lymphocyte responses (Trinchieri, 1998). Notably, this network of
cell interactions has been shown to be involved in the regression of
murine metastatic neuroblastoma (Turner et al, 2001). Thus, CD40
may represent a novel therapeutic, multifunctional target in NB
because of its expression on both tumour cells and professional
antigen-presenting cells. Since, in the present study, surface CD40
was detected on a fraction of neuroblasts from the individual
tumours, CD40L-induced apoptosis of malignant cells and
immune activation may cooperate in the elimination of CD40þ
and CD40  neuroblasts, as already shown in a different neoplastic
model (Dotti et al, 2002).
A trimeric recombinant form of soluble CD40L, recently tested
in Phase I studies with lymphoma or solid tumour bearing
patients, showed limited toxicity, indicating the potential feasi-
bility of this therapeutic approach in NB patients (Vonderheide
et al, 2001a,b).
MATERIALS AND METHODS
Patient samples
This investigation was performed after approval by a local
institutional review board. Four NB tumours were obtained from
the local pathologist (CG). Disease stage according to the
International Neuroblastoma Staging System (Brodeur et al,
1998) was: stage 1 (one case), stage 2 (one case), stage 3 (one
case) and stage 4 (one case). Aliquots of BM aspirates performed
for diagnostic purposes were from six patients with stage 4 disease.
These samples contained at least 25% infiltrating neuroblasts, as
assessed by morphological criteria and anti-GD2 staining.
Cell separation and culture
Solid tumours were minced in RPMI 1640 medium (Seromed-
BiochromKG, Berlin, Germany) supplemented with 10% fetal calf
serum (Seromed) (RPMI-FCS) and subjected to gravity sedimenta-
tion for 2min to remove large debris. Supernatants were used for
further experiments. Bone marrow aspirates were depleted of
erythrocytes by osmotic lysis, washed twice in RPMI–FCS and
tested.
Neuroblastoma cells were isolated as follows. Cells were first
incubated with an anti-GD2 mAb and then positively selected by
immunomagnetic beads coated with anti-mouse immunoglobulin
antibodies, according to the instructions of the manufacturer
(Immunotech, Marseille, France). The source of the anti-GD2 mAb
(IgG2a) was the supernatant of the ME361-S2a murine hybridoma,
purchased from ATCC, Manassas, VA, USA.
The ACN, SK-N-BE, SK-N-BE2(C), SK-N-SH, LAN-1, LAN-5, GI-
LI-N, GI-ME-N, GI-CA-N and IMR-32 NB cell lines, whose features
are described in Thiele (1999), or IFN-g gene-transfected ACN cells
were cultured in RPMI–FCS for the indicated times. IFN-g gene-
transfected ACN cells were generated by one of us (MVC) in
collaboration with Dr Silvano Ferrini, IST, Genova. In some
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(1000IUml
 1) (Imuchin
s, Boehringher Ingelheim Italia, Florence,
Italy) for 72h before undergoing molecular or immunophenotypic
studies. The rIFN-g concentration and the culture time were
selected on the ground of previous studies (Montaldo et al, 1997).
Monoclonal antibodies
Flow cytometric analysis was carried out as reported (Airoldi et al,
2000). Neuroblastoma cells were always stained in parallel with
positive controls, that is, the Colo 205 cell line for OX40L and
4-1BBL staining (Salih et al, 2000), and the Raji cell line for CD40,
CD80 and CD86 staining.
The following murine mAbs were used for single or double
staining: PE-conjugated CD40, FITC-conjugated CD80 and PE-
conjugated CD86mAbs, all from Diaclone (Diaclone SA, Besanc¸on,
France) and anti-GD2 from ATCC (see above). Cells stained with
the latter mAb were washed and incubated with a PE- or FITC-
conjugated goat anti-mouse IgG subclass antiserum (Dako,
Glostrup, Denmark), depending on the partner mAb used in
double staining experiments. Controls for CD40, CD80 and CD86
were fluorochrome-conjugated, isotype-matched murine mAbs of
irrelevant specificity. Control for anti-GD2 staining was purified
murine IgG2a (Southern Biotechnology Associates, Birmingham,
AL, USA) of irrelevant specificity.
In addition, the rhOX40:Fc and rh4-1BB:Fc (Alexis Corp., Del
Mar, CA, USA) fusion proteins, in which the OX40 and 4-1BB
proteins are fused with the Fc portion of human IgG1, were used
for single or double staining. Cells were incubated with the fusion
proteins or with the purified Fc portion of human IgG1 (Alexis
Biochemicals, Lausanne, Switzerland) as control, washed and
stained with FITC-conjugated goat anti human IgG (Fc portion-
specific) antibodies (Alexis).
In some experiments, GI-LI-N, SK-N-BE2(C) and LAN-5 cell
lines that had been preincubated 72h with rIFN-g were washed and
stained with the CD40mAb for 30min at 41C in the dark. Cells
were then washed in PBS containing 1% FCS and fixed in 4% para-
formaldehyde for 20min at 41C in the dark. Afterwards, the cells
were washed twice with permeabilisation buffer (PBS, 1% FCS,
0.1% saponin, Sigma Aldrich, Milano, Italy) and stained with
FITC-conjugated goat anti-mouse antiserum specific for the
appropriate murine IgG subclass or with a FITC-conjugated,
goat antiserum of irrelevant specificity for 30min at 41Ci n
the dark. Cells were washed in staining buffer and analysed
by flow cytometry (FACScan-BD Biosciences-Mountain View,
CA, USA).
Reverse transcription–polymerase chain reaction
and sequencing
RNA was extracted from freshly isolated or cultured cells using
RNeasy Mini Kit from Qiagen (Qiagen GmbH, Hilden, Germany)
and subjected to RT–PCR as reported (Turner et al, 2001). Primer
sequences and profiles of amplification were the following: G3PDH
50 ACATCGCTCAGAACACCTATGG and 30 GGGTCTACATGG-
CAACTGTGAG, CD45 50 CCTACAGACCCAGTTTCC and 30 GGC-
AATCTTTTTCTGTCT, HLA-DRb 50 CTCCAGCATGGTGTGTCT-
GA and 30 GGAGGTTGTGGTGCTGCAGG, CD40 50 CTGGGGCTG-
CTTGCTGAC and 30 TCCTGGGGTTCCTGCTTG, CD80 50 GGTC-
TTTCTCACTTCTGTTC and 30 CTTTCCCTTCTCAATCTCTC,
CD86 50 ACACGGAGGCAGGGAACA and 30 GGAAAATGCTCT-
TGCTTGGT, PD-1L 50 GGGAAATGGAGGATAAGA and 30 AG-
GATGTGCCAGAGGTAG, B7H2 50 CCGAGCCCTGATGTCACC and
30 CCGCCACGACCACAAGCA, 4-1BBL 50 ACAAAGAGGACACGA-
AGGAG and 30 GGAGGAGGCGGGTGGCAGGT, OX40L 50 TCAA-
CATTAGCCTTCATTACC and 30 GAATCAGTTCTCCGCCATTCA.
Amplification profile was 941C for 1min, annealing 601C
(G3PDH), 491C (CD45), 551C (HLA-DRb), 571C (CD40), 521C
(CD80), 541C (CD86), 511C (PD-1L and OX40L), 581C (B7H2),
591C (4-1BBL) for 1min and extension at 721C for 1min. Each
cycle of amplification was repeated 35 times.
A volume of 10ml of each sample were electrophoresed through
a 1% agarose gel containing ethidium bromide. The specificity of
amplification products was checked by confirming the known
base-pair sequence length and by sequencing.
Direct sequencing of PCR products was performed with the use
of the Dye Terminator Cycle Sequencing Kit (ABI PRISM; Perkin-
Elmer Applied Biosystem, Norwalk, CT, USA). Sequences were
resolved and analysed on the ABI 373A Sequence Apparatus
(Perkin-Elmer Applied Biosystem).
For semiquantitative RT–PCR analysis, nonsaturating condi-
tions were used, that is, 1/5 of cDNA previously used and
amplifications with CD40 or G3PDH-specific primers were
performed for 30 cycles.
Assay for assessment of apoptosis
ACN cells transfected with the plasmid carrying the IFN-g gene or
with the empty plasmid were cultured in six-well plates (Costar,
Cambridge, MA, USA) for 5–72h: (i) in the absence or presence of
rCD40L (Immunex, Seattle, WA, USA) at 1mgml
 1. This
concentration was selected on the ground of preliminary titration
experiments in which rCD40L was tested in the range of 0.1–
100mgml
 1, or (ii) NIH3T3 murine fibroblasts transfected with the
pIRES-neo bicystronic plasmid vector carrying the human CD40L
gene or with the empty vector. These cultures were set up at a 4:1
NB/CD40 L or control transfectant cell ratio. The latter transfec-
tants were kindly provided by Dr Franco Fais, Department of
Experimental Medicine, University of Genova, Italy.
Cells were harvested by brief trypsinisation and the proportion
of apoptotic cells was assessed by flow cytometry using an annexin
V–FITC apoptosis kit according to the manufacturer’s instruction
(Bender MedSystems, Vienna, Austria). In this assay, cells double
staining for annexin and propidium iodide are apoptotic, whereas
cells single positive for propidium iodide staining are necrotic. In
the experiments in which murine fibroblasts were cocultured with
neuroblasts, the latter cells were first gated on the basis of their
larger size and then analysed by double staining for annexin and
propidium iodide. Gated cells were uniformly GD2þ, as assessed
by flow cytometry.
For inhibition of apoptosis studies, IFN-g gene-transfected ACN
cells were preincubated overnight with the selective caspase-8
inhibitor, Z-LE(Ome)-TD(Ome)-FMK (Alexis) at the final con-
centration of 20mM before adding rCD40L. The cultures were
supplemented with Z-LETD-FMK every 24h. Cells were harvested
and assessed for apoptosis by flow cytometry as described above.
Total extracts and Western blot analysis
Cells were incubated for 30min on ice with lysis buffer containing
20mM HEPES, 150mM NaCl, 10% glycerol, 0.5%. NP-40, 1mM
EDTA, 2.5mM DTT, 10mgml
 1 aprotinin, 10mgml
 1 leupeptin,
1mgml
 1 pepstatin A, 1mM PMSF and 1mM Na3VO4, all from
Sigma-Aldrich. During this time interval, cells were subjected to
vortex mixing every 5min. Thereafter, lysates were centrifuged at
12000r.p.m. for 5min at 41C and supernatants quantitated by the
BCA kit assay (Pierce, Rockford, IL, USA). Equal amounts of
protein (10mg) were loaded on 8% SDS–polyacrylamide gel and
boiled 3min before application. Gel was blotted onto Protean
nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany)
for 1h at 100V. Blots were incubated in a blocking buffer
containing BSA and 0.5% Tween-20 in Tris-buffered saline (TBS)
for 1h, followed by incubation with goat anti-human Caspase-8
antiserum (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA).
After three washings in TBS–Tween, blots were incubated for 1h
with rabbit anti-goat Ig conjugated with horseradish peroxidase
Costimulatory molecules in neuroblastoma
I Airoldi et al
1534
British Journal of Cancer (2003) 88(10), 1527–1536 & 2003 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
y(Santa Cruz) at the final concentration of 50ngml
 1 in TBS–
Tween containing 1% BSA. Detection was performed by enhanced
chemiluminescence (ECL, Pierce, NE, USA).
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